PALS2

PALS2 (MPP6/VAM-1/p55T) is a basolateral membrane-associated guanylate kinase (MAGUK) scaffolding protein that nucleates multiprotein complexes linking cell-adhesion molecules to the membrane cytoskeleton (PMID:10753959, PMID:17267446). It was first defined by its ability to bind the amino terminus of the Lin-7/Veli family of adaptor proteins through a conserved Lin-7-binding (L27-type) domain, with site-directed mutagenesis identifying the residues required for this interaction, and it localizes to the lateral membrane of polarized epithelial cells (PMID:10753959, PMID:11311936). PALS2 engages the cytoplasmic tails of nectin-like cell-adhesion molecules Necl-2 (SynCAM1) and Necl-1 (SynCAM3) at non-junctional basolateral contact sites, behaving as a conserved adhesion-complex scaffold distinct from the apical polarity machinery — a role mirrored by its Drosophila ortholog Varicose binding Neurexin IV (PMID:12826663, PMID:15741237, PMID:17267446). In peripheral nerve myelin it assembles with Cadm4, Lin7, and band 4.1G (Epb41l2) into a membrane-skeletal complex at Schmidt-Lanterman incisures, and it marks cone but not rod photoreceptors (PMID:35445918, PMID:41396450). Beyond scaffolding, PALS2 forms a complex with GSDME in vascular smooth muscle cells and acts upstream of caspase-3 activation and GSDME cleavage during apoptosis (PMID:38851795). Its specificity among MAGUKs is underscored by its failure to interact with SAP97 despite SAP97 binding the related MAGUKs DLG2 and DLG3 (PMID:12351654).

1. 2000 High

   Established PALS2 as a distinct MAGUK that selectively recruits the Lin-7 adaptor, defining the molecular basis for a new class of lateral-membrane targeting complexes.

   Evidence Far Western overlay, expression cloning, and site-directed mutagenesis with immunofluorescence in MDCK cells

   PMID:10753959

   Open questions at the time

   • Functional consequence of the Lin-7 interaction not tested
   • No physiological ligand of the PDZ/SH3/GUK module identified
2. 2001 Medium

   Confirmed the conserved Lin-7/Veli-binding domain and provided domain architecture and tissue-expression context, generalizing the interaction across species homologues.

   Evidence GST pull-down and blot overlay in heterologous transfection, FISH chromosomal mapping

   PMID:11311936

   Open questions at the time

   • Interaction shown in heterologous systems only
   • No endogenous complex demonstrated
3. 2003 Medium

   Connected PALS2 to a transmembrane adhesion molecule by showing it binds Necl-2 at the basolateral membrane, implicating PALS2 in localizing cell-adhesion proteins.

   Evidence Protein binding assays plus immunofluorescence in mouse gall bladder epithelium

   PMID:12826663

   Open questions at the time

   • Direct vs indirect binding to Necl-2 not fully resolved
   • No loss-of-function test of trafficking role
4. 2002 Medium

   Defined the binding specificity of PALS2 within the MAGUK family by demonstrating it does not associate with SAP97, distinguishing it from DLG2/DLG3.

   Evidence Co-immunoprecipitation and binding assays in rat brain lysates and MDCK cells

   PMID:12351654

   Open questions at the time

   • Negative result; structural basis of exclusion not defined
5. 2004 Low

   Placed PALS2 among MAGUKs associated with a potassium channel C-terminal motif, raising a possible channel-anchoring role in brain.

   Evidence Affinity chromatography on Kir2.2 C-terminal matrix with HPLC-ESI-MS/MS and immunoblotting from rat brain

   PMID:15024025

   Open questions at the time

   • Proteomic co-isolation only; no direct PALS2-Kir2.2 interaction or functional follow-up
   • PALS2-specific contribution not isolated from eight co-purifying MAGUKs
6. 2005 Low

   Extended the adhesion-scaffold role to the nervous system by showing PALS2 binds the neural cell-adhesion molecule Necl-1 at non-junctional contacts.

   Evidence Binding assays with the Necl-1 C-terminal cytoplasmic region

   PMID:15741237

   Open questions at the time

   • Single binding assay without reciprocal or functional validation
   • Endogenous complex not demonstrated
7. 2007 Medium

   Used the Drosophila ortholog Varicose to establish PALS2 as part of a conserved basolateral cell-adhesion complex separable from the apical polarity complex.

   Evidence Phylogenetic analysis with in vivo localization and genetic loss-of-function in Drosophila

   PMID:17267446

   Open questions at the time

   • Functional parallel inferred from ortholog rather than mammalian loss-of-function
   • Mammalian PALS2 phenotype not tested
8. 2022 Medium

   Defined a membrane-skeletal complex containing PALS2, Cadm4, Lin7, and band 4.1G at Schmidt-Lanterman incisures of peripheral myelin, anchoring PALS2 in a specific subcellular myelin domain.

   Evidence Mass spectrometry proteomics of purified myelin from Fa2h-/- mouse sciatic nerves

   PMID:35445918

   Open questions at the time

   • Complex composition from co-purification; direct binding not mapped
   • Functional role of the complex in myelin maintenance not established
9. 2024 Medium

   Revealed a non-scaffolding apoptotic function by showing PALS2 complexes with GSDME and acts upstream of caspase-3 activation and GSDME cleavage in vascular smooth muscle cells.

   Evidence Reciprocal co-immunoprecipitation and siRNA knockdown with Western readout for activated caspase-3 and GSDME fragmentation in VSMCs

   PMID:38851795

   Open questions at the time

   • Mechanism by which PALS2 promotes caspase-3 activation unknown
   • Single cell type and single lab
10. 2025 Medium

    Established cell-type-specific expression by identifying PALS2 as a pan-cone, rod-absent photoreceptor protein, suggesting a specialized role in cone photoreceptors.

    Evidence FACS-sorted mouse retinal cells with DIA mass spectrometry proteomics

    PMID:41396450

    Open questions at the time

    • Localization only; no functional role in cones tested
    • Binding partners in cones not identified

• How PALS2's scaffolding activity mechanistically connects to its apoptotic role with GSDME, and what its function is in cone photoreceptors and myelin incisures, remain unresolved.
• No structural model of PALS2 in its complexes
• No mammalian loss-of-function phenotype linking scaffolding to physiology
• Mechanism linking PALS2 to caspase-3 activation undefined